Participation in adjuvant clinical breast cancer trials: Does study participation improve survival compared to guideline adherent adjuvant treatment? A retrospective multi-centre cohort study of 9433 patients-Reference-Cited by-同舟云学术

Participation in adjuvant clinical breast cancer trials: Does study participation improve survival compared to guideline adherent adjuvant treatment? A retrospective multi-centre cohort study of 9433 patients

Published:2013-02 Issue:3 Volume:49 Page:553-563
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Schwentner L.,Van Ewijk R.,Kurzeder C.,Hoffmann I.,König J.,Kreienberg R.,Blettner M.,Wöckel A.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference25 articles.

1. Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists;Badve;Mod Pathol,2011

2. Triple-negative/basal-like breast cancer: review;Rakha;Pathology,2009

3. Triple negative breast cancer: unmet medical needs;Pal;Breast Cancer Res Treat,2011

4. Future cancer incidents in Germany;Haberland;Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz,2006

5. Results of a breast cancer surgery trial compared with observational data from routine practice;Marubini;Lancet,1996

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing Real-World Evidence to Advance Cancer Research;Current Oncology;2023-02-02

2. Outcome analysis of primary breast cancer patients who declined adjuvant chemotherapy—results from the prospective multi-center BRENDA II study;Breast Cancer;2022-02-18

3. Do hospital type or caseload make a difference in chemotherapy treatment patterns for early breast cancer? Results from 104 German institutions, 2008–2017;The Breast;2021-08

4. Factors influencing treatment decision and guideline conformity in high-grade endometrial cancer patients: a population-based study;Archives of Gynecology and Obstetrics;2021-07-05

5. Clinical Predictors of Early Trial Discontinuation for Patients Participating in Phase I Clinical Trials in Oncology;Cancers;2021-05-11